| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 247.69B | 243.48B | 231.51B | 230.19B | 210.69B | 196.73B |
| Gross Profit | 96.90B | 93.74B | 89.95B | 86.06B | 85.21B | 82.87B |
| EBITDA | 35.89B | 33.15B | 30.84B | 31.14B | 31.19B | 30.66B |
| Net Income | 11.09B | 9.22B | 8.48B | 6.46B | 8.97B | 8.81B |
Balance Sheet | ||||||
| Total Assets | 217.16B | 214.90B | 209.12B | 193.34B | 184.47B | 178.97B |
| Cash, Cash Equivalents and Short-Term Investments | 6.09B | 5.64B | 5.76B | 4.36B | 4.74B | 5.58B |
| Total Debt | 54.46B | 65.09B | 65.53B | 64.91B | 61.25B | 57.41B |
| Total Liabilities | 117.27B | 119.04B | 117.82B | 111.03B | 105.52B | 102.91B |
| Stockholders Equity | 97.37B | 93.47B | 89.08B | 80.22B | 77.24B | 74.51B |
Cash Flow | ||||||
| Free Cash Flow | 10.27B | 11.43B | 13.09B | 6.97B | 7.25B | 19.09B |
| Operating Cash Flow | 26.87B | 25.80B | 30.08B | 21.23B | 20.84B | 32.17B |
| Investing Cash Flow | -16.05B | -15.83B | -19.15B | -14.46B | -14.90B | -17.31B |
| Financing Cash Flow | -10.77B | -10.13B | -9.36B | -7.19B | -6.63B | -13.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥184.41B | 12.04 | 8.27% | 2.68% | -2.45% | 7.31% | |
75 Outperform | ¥151.95B | 9.78 | ― | 2.66% | -1.63% | 67.13% | |
73 Outperform | ¥243.63B | 9.23 | ― | 3.90% | 2.65% | 7.16% | |
68 Neutral | ¥156.67B | 9.03 | ― | 3.17% | 3.99% | 20.63% | |
65 Neutral | ¥259.94B | 14.72 | 8.35% | 2.73% | 3.35% | 810.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥166.69B | 8.92 | 9.14% | 2.84% | 0.26% | 14.29% |